P19888 Type II methyltransferase M.BanI MolNFT, Molecular NFT on GenesisL1

Type II methyltransferase M.BanI

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeialh6x4bfmul36feskkzu34i3syzu3hm73iobmbnxf7sy2tllgs6e/metadata.json

IPFS of structure file:

bafybeiazlmbskrqqdy3wakbxntxhh5zviooqyyiwifxdqs5eu2fybd3s74/AF-P19888-F1-model_v2.pdb

First NFT owner address (eip-55):

0xcFf9BA0aF3DBABCc89e611059882CCFef4E731f4

First NFT owner address (bech32):

genesis1elum5zhnmw4uez0xzyze3qkvlm6wwv05hgdmw0

Current NFT ID #246843 owner (web3):

0x1309d1b5deb373471d3FB243145F68f72a78D518

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
246843
Accession (UniProt):
P19888
Name::
Type II methyltransferase M.BanI
Experimental Method:
Predicted structure
Sequence source:
Aneurinibacillus aneurinilyticus

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P19888 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P19888|MTBA_ANEAE Type II methyltransferase M.BanI OS=Aneurinibacillus aneurinilyticus OX=1391 GN=banIM PE=1 SV=1 MKIKFVDLFAGIGGIRIGFERAAKRFELETECVLSSEIDKKACETYALNFKEEPQGDIHEITSFPEFDFLLAGFPCQPFSYAGKQQGFGDTRGTLFFEVERVLRDNRPKAFLLENVRGLVTHDKGRTLKTIISKLEELGYGVSYLLLNSSTFGVPQNRVRIYILGILGSKPKLTLTSNVGAADSHKYKNEQISLFDESYATVKDILEDSPSEKYRCSDEFIGQLSKVVGNNFELLHGYRLIDYRGGNSIHSWELGIKGDCTKEEIEFLNQLIANRRKKIYGTHQDGKALTLEQIRTFYNHDQLEVIIKSLLQKGYLREEENKFNPVCGNMSFEVFKFLDPDSISITLTSSDAHKLGVVQNNVPRRITPRECARLQGFPDDFILHSNDNFAYKQLGNSVTVKVVEKVIEDLFQNNVNELFGQMKLANVV

P19888 AF NFT

MOLNFT AF v1

NFT data

MOLNFT P19888 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience